Drug intelligence / Profile preview

i-FACTOR

Development stage
Phase 4
Lead developer
Cerapedics
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Peptides, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Surgical Implantation
01

Overview

i-FACTOR is a peptide-enhanced bone graft indicated for use in skeletally mature patients undergoing reconstruction of a degenerated cervical disc at one level (C3-C4 to C6-C7) following single-level discectomy for intractable radiculopathy or myelopathy. It is the first spinal bone graft powered by the P-15 Osteogenic Cell Binding Peptide, which synthetically replicates a segment of type I collagen that facilitates cellular attachment in connective tissues. The mechanism involves the surface-bound P-15 peptide chemically bound to calcium phosphate particles, attracting and activating bone-forming cells to promote bone growth and fusion. i-FACTOR is FDA approved as a Class III device for single-level anterior cervical discectomy and fusion (ACDF), demonstrating high fusion rates and statistical superiority over local autograft in clinical trials[1][2][4][5][6].

Brand names
i-FACTORi-FACTOR Peptide Enhanced Bone GraftP-15 Peptide Enhanced Bone GraftP15 Peptide Enhanced Bone GraftP 15 Peptide Enhanced Bone Graft
Other names
i-FACTORi-FACTOR Peptide Enhanced Bone GraftP-15 Peptide Enhanced Bone GraftP15 Peptide Enhanced Bone GraftP 15 Peptide Enhanced Bone Graft
02

Targets

ITGA2/ITGB1 (Integrin alpha-2/beta-1 receptor)

Beyond the preview

Go deeper on i-FACTOR.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on i-FACTOR.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call